A 15β-subsitituted steroidal compound.
PK140898AUndetermined Publication Date: 2010-09-20NV ORGANON
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200500835
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-09-20
Abstract
The invention provides 15β-substituted steroidal compound / 6 having selective estrogen receptor activity according to Formula1: Wherein, R1 is H, C1-5 alkyl, C1-12acyl,di-(C15alkyDaminocarbonyl,(C1-5alkyl)oxycarbonyl or sulfamoyl, R2 is H, C1-3alkyl, C2-3alkenyl or C23alkynyl, each of which may be optionally substituted with a halogen, R3 is C1-2 alkyl, ethenyl or ethynyl, each of which may be optionally substituted with a halogen, and R4 is H or C1-12acyl.
Need to check novelty before this filing date? Find Prior Art